secwatch.observer — SEC 8-K summary
======================================

Issuer:     BioAge Labs, Inc. (BIOA)
CIK:        0001709941
Form:       8-K
Filed at:   2024-09-27T23:59:59+00:00
Accession:  0001193125-24-227949
Event type: other_material
Sentiment:  neutral
Materiality: 0.35
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BioAge Labs sells 588,888 shares to Sofinnova at $18 in private placement concurrent with IPO
--------------------------------------------------------------------------------

- Private placement of 588,888 shares to existing stockholder Sofinnova at IPO price of $18.00/share, raising $10.6 million.
- Placement agents Goldman Sachs, Morgan Stanley, Jefferies, Citigroup received 7.0% fee on total purchase price.
- Shares unregistered, issued under Section 4(a)(2) to an institutional accredited investor; registration rights after one year if not saleable under Rule 144.
- Closing occurred on September 27, 2024, concurrently with the IPO closing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1709941/000119312524227949/0001193125-24-227949-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1709941/000119312524227949/d890673d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-227949

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer